Optimization of the EX vivo 3-dimensional culture conditions that controls the formation and development of human hematopoietic stem and progenitor cell populations
Ended Project Grant Awarded Last action
- Award ID
- R43HL150906
- Recipient
-
Quality Biological Inc. UEI V7ACWSNAL845
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $23,435
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Funding
-
- $71,921.00 Federal
- -$48,486.00 Non-federal
- Place of performance
- Montgomery Village, MD 20879, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | -$48,486 | $0 | |
| Amendment | -$48,486 | $0 | |
| Amendment | -$48,486 | -$48,486 | |
| Original award | $217,379 | $0 |
Quick answers
Who received award R43HL150906?
R43HL150906 was awarded to Quality Biological Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 24, 2020.
How much is award R43HL150906 worth?
$23,435 has been obligated on R43HL150906: $71,921 in federal funding and -$48,486 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award